BILATERAL CYSTOID MACULAR EDEMA AFTER BIMATOPROST IMPLANTS

Area of Science:

• Ophthalmology
• Glaucoma treatment
• Macular edema

Background:

• Primary open-angle glaucoma is a progressive optic neuropathy.
• Bimatoprost implant (Durysta) is a sustained-release formulation for glaucoma management.

Observation:

• A case report details a 93-year-old woman treated with bilateral bimatoprost implants for primary open-angle glaucoma.
• The patient experienced decreased visual acuity in both eyes following the injections.

Findings:

• Bilateral cystoid macular edema was diagnosed as the cause of vision loss.
• The condition improved with topical corticosteroid treatment.

Implications:

• Bimatoprost implant (Durysta) may induce cystoid macular edema in some patients.
• Post-injection monitoring for visual acuity decline is crucial, especially in high-risk individuals.